Filing Details

Accession Number:
0001493152-22-014518
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-19 17:58:59
Reporting Period:
2022-05-18
Accepted Time:
2022-05-19 17:58:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX In Vitro & In Vivo Diagnostic Substances (2835) 271041563
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777275 Li Yu 15 Cushing
Irvine CA 92618
Vp Cntrllr/Prncpl Acctng Offcr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2022-05-18 25,000 $0.00 25,000 No 4 M Direct
Common Stock, No Par Value Disposition 2022-05-18 8,128 $1.14 16,872 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-05-18 25,000 $0.00 25,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 No 4 M Direct
Footnotes
  1. Represents shares sold to cover the tax liability arising from the vesting of Restricted Stock Units.
  2. Restricted Stock Units vested on May 18, 2022.